Current Investigations


  • All
  • Antitrust Litigation
  • Consumer Protection Litigation
  • Securities Litigation
  • Shareholder Derivative Litigation
  • Shareholder Merger Litigation
  • Employment Litigation

02 Sep 2025

Semler Scientific, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Semler Scientific To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Semler ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

27 Aug 2025

LifeMD, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in LifeMD between May ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

25 Aug 2025

Nutex Health Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Nutex between August ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

21 Aug 2025

PubMatic, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PubMatic To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in PubMatic between ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

18 Aug 2025

Unicycive Therapeutics, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Unicycive To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Unicycive between ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

15 Aug 2025

Charter Communications, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charter To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Charter between ...

Robert W. Killorin, James M. Wilson, Jr. at New York office

Read more

12 Aug 2025

SelectQuote, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in SelectQuote between ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

11 Aug 2025

CTO Realty Growth, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CTO To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in CTO between February ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

06 Aug 2025

Altimmune, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Altimmune between ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

01 Aug 2025

Novo Nordisk A/S

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Novo To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Novo between May 7, ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

29 Jul 2025

Lockheed Martin Corporation

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lockheed Martin To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Lockheed ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

28 Jul 2025

Sable Offshore Corp.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 Sable Offshore To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Sable Offshore ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

25 Jul 2025

RxSight, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in RxSight between November ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

25 Jul 2025

Fiserv, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Fiserv To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Fiserv between July ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

25 Jul 2025

Flywire Corporation

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Flywire To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Flywire between February ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

22 Jul 2025

Replimune Group, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Replimune between ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

21 Jul 2025

Alto Neuroscience, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Alto To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Alto (a) Alto common ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

18 Jul 2025

Capricor Therapeutics, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Capricor between ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

14 Jul 2025

Biohaven Ltd.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Biohaven To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Biohaven between ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

09 Jul 2025

Centene Corporation

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Centene To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Centene between December ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania